source
- FDA releases FY 2027 user fee rates for prescription, generic, biosimilar, device and over the counter programsThe U.S. Food and Drug Administration has published its user fee schedule for fiscal year 2027. The rates cover prescription drugs, generic drugs, biosimilars, medical devices and over the counter…
- Heart Pump Recall: Abiomed Removes Impella CP Sets with SmartAssistSpecific Impella CP Sets are out of specification; use may result in low purge pressure events from the onset of the casefda medwatch · 1mo ago↗ source